首页

所有产品分类

所有产品

信号通路

研究领域

天然产物

抗体

多肽

催化剂

杂质对照品

医药中间体

基础原料

所有产品

结构式 货号 产品名称 CAS号
Durlobactam 结构式
BCP42819 Durlobactam 1467829-71-5
Durlobactam is a beta-lactamase inhibitor drug candidate.
QPX7728 结构式
BCP42817 QPX7728 2170834-63-4
QPX7728 is an of ultra-broad-spectrum boronic acid beta-lactamase.
Tazobactam Diphenylmethyl Ester 结构式
BCP42816 他唑巴坦二苯甲酯 89789-07-1
Mito-LND 结构式
BCP42814 Mito-LND 2361564-49-8
Mito-LND is an orally active and mitochondria-targeted inhibitor of oxidative phosphorylation (OXPHOS).
PF-562271HCl 结构式
BCP42811 PF-562271 HCl 939791-41-0
PF-562271 is an orally bioavailable small molecule and ATP-competitive focal adhesion kinase (FAK) inhibitor with potential antineoplastic and antiangiogenic activities.
Prostaglandin G2 结构式
BCP42810 前列腺素 G2 51982-36-6
Prostaglandin G2 is a prostaglandins G.
PF07104091 结构式
BCP42948 PF07104091 2460249-19-6
PF-07104091 is an orally bioavailable inhibitor of cyclin-dependent kinase 2 (CDK2), with potential antineoplastic activity.
M4205 结构式
BCP42947 M4205 2590556-80-0
M4205 is a c-KIT inhibitor, with an IC50 of 10 nM for c-KIT V654A. M4205 has high activity on c-KIT mutations in exon 11, 13, 17.
HM43239 结构式
BCP40967 HM43239 2569527-64-4
HM43239 is an orally active small molecule inhibitor of FLT3 that selectively inhibits not only FLT3 wild type, ITD mutants or TKD mutations, but also FLT3 ITD/TKD double mutations.
Venadaparib 结构式
BCP42946 Venadaparib 1681017-83-3
Venadaparib is an antineoplastic.Venadaparib is a potent, selective and orally active PARP inhibitor with IC50s of 1.4 nM and 1.0 nM for PARP1 and PARP2, respectively.
123下一页末页共 25501 条记录 1 / 2551 页 
2853530911